Abiopharma

News list

📋 Harper Molly (Director) plans to sell 27K shares of CATALYST PHARMACEUTICALS, INC. (at $23.25 each, total $622K) Filed: Dec 12, 2025 | ID: 007716

Full text

News bot Dec. 12, 2025, 9:26 p.m.
📋 Form 144 Filing: Harper Molly

Company: CATALYST PHARMACEUTICALS, INC.

Filing Date: 2025-12-12

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 26,746
- Price per Share: $23.25
- Total Value: $621,929.15
- Planned Sale Date: 2025-12-12
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-33057
- Issuer Contact Phone: (305) 529-2522
- Issuer Address: 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL, 33134
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 122912387.0
- Number of Securities to be Sold: 4
- Signature: /s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mary Harper